Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β
- PMID: 28918679
- DOI: 10.1080/0284186X.2017.1371325
Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β
Abstract
Background: Proton therapy uses a constant relative biological effectiveness (RBE) of 1.1. The use of variable RBE values has been suggested but is currently not feasible due to uncertainties. The impact of variable RBE has solely been studied using dosimetric indices. This work elucidates the impact of RBE variations on tumor control and normal tissue complication probabilities (TCP/NTCP).
Methods: Models to estimate TCP and NTCP were used in combination with an empirical proton RBE model. Variations in outcome as a function of linear-quadratic model parameters for cellular radiosensitivity were determined for TCP in prostate and ependymoma. In addition, NTCP analysis was done for brainstem necrosis.
Results: Considering a variable proton RBE as a dose-modifying factor for prescription doses and dose constraints is misleading, as TCP/NTCP do not simply scale with RBE. The dependency of RBE on α/β cannot be interpreted independent of TCP/NTCP because variations in radiosensitivity affect both photon and proton treatments. Assuming interpatient variability in radiosensitivity results in lower TCP for patients with low α/β. In proton therapy, the magnitude of TCP variations is reduced due to an RBE increase as α/β decreases. The TCP in proton therapy is less affected by interpatient variability in α/β. On the other hand, patients with a lower α/β would have a lower complication probability, which is counteracted by an increase in RBE as α/β decreases. Toxicities in proton therapy would be more affected by α/β variations compared to photon therapy.
Conclusions: Assessment of variable RBE in proton therapy should be based on TCP and NTCP. Potential interpatient variability in radiosensitivity causes a smaller variance in TCP but a larger variance in NTCP for proton patients. The relative TCP as a function of α/β was found to be higher than the RBE, whereas the relative NTCP was lower than a calculated RBE.
Similar articles
-
Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.Med Phys. 2017 Mar;44(3):810-822. doi: 10.1002/mp.12117. Med Phys. 2017. PMID: 28107554
-
Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer.Phys Med Biol. 2019 Jun 5;64(11):115027. doi: 10.1088/1361-6560/ab2144. Phys Med Biol. 2019. PMID: 31082810
-
Impact of potentially variable RBE in liver proton therapy.Phys Med Biol. 2018 Sep 21;63(19):195001. doi: 10.1088/1361-6560/aadf24. Phys Med Biol. 2018. PMID: 30183674 Free PMC article.
-
Relative Biological Effectiveness Uncertainties and Implications for Beam Arrangements and Dose Constraints in Proton Therapy.Semin Radiat Oncol. 2018 Jun;28(3):256-263. doi: 10.1016/j.semradonc.2018.02.010. Semin Radiat Oncol. 2018. PMID: 29933885 Review.
-
Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.Phys Med Biol. 2014 Nov 21;59(22):R419-72. doi: 10.1088/0031-9155/59/22/R419. Epub 2014 Oct 31. Phys Med Biol. 2014. PMID: 25361443 Review.
Cited by
-
Proton relative biological effectiveness (RBE): a multiscale problem.Br J Radiol. 2019 Jan;92(1093):20180004. doi: 10.1259/bjr.20180004. Epub 2018 Jul 26. Br J Radiol. 2019. PMID: 29975153 Free PMC article. Review.
-
Roadmap: proton therapy physics and biology.Phys Med Biol. 2021 Feb 26;66(5):10.1088/1361-6560/abcd16. doi: 10.1088/1361-6560/abcd16. Phys Med Biol. 2021. PMID: 33227715 Free PMC article. Review.
-
Influence of beam pruning techniques on LET and RBE in proton arc therapy.Front Oncol. 2023 Sep 5;13:1155310. doi: 10.3389/fonc.2023.1155310. eCollection 2023. Front Oncol. 2023. PMID: 37731633 Free PMC article.
-
Ensemble RBE Modeling in Proton Therapy: A Meta-Synthesis Framework for Dose Assessment in the Brainstem and Spinal Cord.Cancer Control. 2025 Jan-Dec;32:10732748251355396. doi: 10.1177/10732748251355396. Epub 2025 Jul 1. Cancer Control. 2025. PMID: 40591455 Free PMC article.
-
Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.J Appl Clin Med Phys. 2019 Aug;20(8):36-46. doi: 10.1002/acm2.12676. Epub 2019 Jul 25. J Appl Clin Med Phys. 2019. PMID: 31343826 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical